Skip to main content

Table 1 Patient characteristics of patients who received spinal reirradiation (n = 44)

From: Overall survival after reirradiation of spinal metastases – independent validation of predictive models

  

Number of patients

Sex

Female

21

 

Male

23

Primary tumor site

Breast

17

Prostate

9

Kidney (renal cell carcinoma)

6

Lung (non-small cell lung cancer)

3

Rectum

2

Esophagus

2

Head and Neck

1

Thyroid

1

Unknown primary

1

Sarcoma

1

Pancreas

1

Number of spinal metastases

n = 1

7

n = 2

14

n ≥ 3

23

Palsy

No

32

Incomplete

8

Complete

4

Number of extraspinal bone metastases

n = 0

13

n = 1

13

n = 2

4

n ≥ 3

14

Visceral metastases

No

18

Yes

26

Potentially removable

6

Liver metastases

No

35

Yes

9

Lung metastases

No

34

Yes

10

Brain metastases

No

40

Yes

4

Pleural effusion

No

31

Yes

6

Unknown (no examination documented)

7

Steroid use at time of presentation

No

26

Yes

9

Unknown

9

Age at start of reirradiation

Median (range)

67 (39–88)

KPS at start [end] of reirradiation

Median

70 [70]

Range

30–100 [20–100]

Site of reirradiation [site of first irradiation]

Cervical spine

1 [3]

Cervical and thoracic spine

5 [4]

Thoracic spine

14 [14]

Thoracic and lumbar spine

6 [5]

Lumbar spine

10 [10]

Lumbar spine and os sacrum

4 [6]

Os sacrum

2 [2]

Overlapping more than 2 areas

2 [0]

Period between 1st irradiation and reirradiation (same site, in months)

Median

21

Range

4-120